BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33564083)

  • 21. P2X1-initiated p38 signalling enhances thromboxane A2-induced platelet secretion and aggregation.
    Huang Z; Liu P; Zhu L; Li N; Hu H
    Thromb Haemost; 2014 Jul; 112(1):142-50. PubMed ID: 24633352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of picotamide on the calcium mobilization and phospholipase C activation in human platelets.
    Pulcinelli FM; Pignatelli P; Riondino S; Parisi S; Castiglioni C; Gazzaniga PP
    Thromb Res; 1994 Jun; 74(5):453-61. PubMed ID: 8085246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation.
    Roger S; Pawlowski M; Habib A; Jandrot-Perrus M; Rosa JP; Bryckaert M
    FEBS Lett; 2004 Jan; 556(1-3):227-35. PubMed ID: 14706855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
    Hanasaki K; Arita H
    Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociation between the phospholipases C and A2 activities in stimulated platelets and their involvement in the arachidonic acid liberation.
    Faili A; Emadi S; Vargaftig BB; Hatmi M
    Br J Haematol; 1994 Sep; 88(1):149-55. PubMed ID: 7803237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
    Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
    Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
    Bleasdale JE; Thakur NR; Gremban RS; Bundy GL; Fitzpatrick FA; Smith RJ; Bunting S
    J Pharmacol Exp Ther; 1990 Nov; 255(2):756-68. PubMed ID: 2147038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1, 6-di-O-caffeoyl-β-D-glucopyranoside, a natural compound from Callicarpa nudiflora Hook impairs P2Y
    Fu J; Zhu X; Wang W; Lu H; Zhang Z; Liu T; Xu H; Fu H; Ma S; Luo Y
    Phytomedicine; 2017 Dec; 36():273-282. PubMed ID: 29157825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
    Vezza R; Mezzasoma AM; Venditti G; Gresele P
    Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of thromboxane receptor activation in human platelets.
    Murray R; FitzGerald GA
    Proc Natl Acad Sci U S A; 1989 Jan; 86(1):124-8. PubMed ID: 2521385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal platelet response to thromboxane A2.
    Wu KK; Le Breton GC; Tai HH; Chen YC
    J Clin Invest; 1981 Jun; 67(6):1801-4. PubMed ID: 6263954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet dysfunction caused by a novel thromboxane A
    Bugert P; Fischer L; Althaus K; Knöfler R; Bakchoul T
    Platelets; 2020; 31(2):276-279. PubMed ID: 31389738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of a bleeding disorder characterized by platelet unresponsiveness to thromboxane A2.
    Fuse I; Higuchi W; Aizawa Y
    Semin Thromb Hemost; 2000; 26(1):43-5. PubMed ID: 10805281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of ganodermic acid S on the thromboxane A2-signaling pathways in human platelets.
    Su CY; Shiao MS; Wang CT
    Biochem Pharmacol; 1999 Aug; 58(4):587-95. PubMed ID: 10413295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
    Lévy-Toledano S; Grelac F; Caen JP; Maclouf J
    Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles.
    Barry OP; Pratico D; Lawson JA; FitzGerald GA
    J Clin Invest; 1997 May; 99(9):2118-27. PubMed ID: 9151784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propofol has both enhancing and suppressing effects on human platelet aggregation in vitro.
    Hirakata H; Nakamura K; Yokubol B; Toda H; Hatano Y; Urabe N; Mori K
    Anesthesiology; 1999 Nov; 91(5):1361-9. PubMed ID: 10551587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemorrhagic thrombocytopathy with platelet thromboxane A2 receptor abnormality: defective signal transduction with normal binding activity.
    Ushikubi F; Okuma M; Kanaji K; Sugiyama T; Ogorochi T; Narumiya S; Uchino H
    Thromb Haemost; 1987 Apr; 57(2):158-64. PubMed ID: 2955539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
    Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
    Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bleeding tendency and impaired platelet function in a patient carrying a heterozygous mutation in the thromboxane A2 receptor.
    Kamae T; Kiyomizu K; Nakazawa T; Tadokoro S; Kashiwagi H; Honda S; Kanakura Y; Tomiyama Y
    J Thromb Haemost; 2011 May; 9(5):1040-8. PubMed ID: 21342433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.